Results 81 to 90 of about 2,828,108 (149)

Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management

open access: yesHematology, Transfusion and Cell Therapy
The use of strategies to reduce blood loss and transfusions is essential in the treatment of surgical patients, including in complex cardiac surgeries and those that use cardiopulmonary bypass.
Juan Carlos Montano-Pedroso   +7 more
doaj   +1 more source

Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials

open access: yesBMC Cardiovascular Disorders, 2005
Background Aprotinin has been shown to be effective in reducing peri-operative blood loss and the need for re-operation due to continued bleeding in cardiac surgery.
Stokes Barrie J   +3 more
doaj   +1 more source

Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis

open access: yesChinese Medical Journal, 2019
. Background:. Significant blood loss is still one of the most frequent complications in spinal surgery, which often necessitates blood transfusion. Massive perioperative blood loss and blood transfusion can create additional risks. Aprotinin, tranexamic
Lei Yuan   +7 more
doaj   +1 more source

Comparison of Efficacy and Safety of Two Commercial Artificial Tears Between 0.18% and 0.3% Sodium Hyaluronate for Corneal Epithelial Healing in Pterygium Excision with Conjunctival Autograft Transplantation: A Study Protocol for a Randomized Controlled Trial

open access: yesClinical Ophthalmology, 2022
Winai Chaidaroon, Suphitcha Pantarote, Phit Upaphong, Janejit Choovuthayakorn Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandCorrespondence: Winai Chaidaroon, Department of Ophthalmology, Faculty of Medicine,
Chaidaroon W   +3 more
doaj  

Repurposing tranexamic acid as an anticancer drug: a systematic review and meta-analysis

open access: yesJournal of Cancer Research and Clinical Oncology
Purpose Drug repurposing may be an efficient strategy for identifying new cancer treatments. Tranexamic acid (TXA), an antifibrinolytic agent that affects the plasminogen-plasmin pathway, may have potential anticancer effects by influencing tumor cell ...
Karoline Assifuah Kristjansen   +3 more
doaj   +1 more source

Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?

open access: yes, 2006
International audienceStudies have shown that antifibrinolytic (aprotinin, tranexamic acid, epsilon-aminocaproic acid) reduce blood loss in orthopedic surgery. However, most lacked sufficient power to evaluate the efficacy and safety on clinical outcomes.
Mismetti, Patrick   +7 more
core   +2 more sources

A Randomized Trial of the Topical Effect of Antifibrinolytic Epsilon Aminocaproic Acid on Coronary Artery Bypass Surgery Without Cardiopulmonary Bypass

open access: yes, 2014
We assessed the effect of the topical application of epsilon-aminocaproic antifibrinolytic acid (EACA) on the pericardium of patients submitted to coronary artery bypass graft (CABG) without the use of cardiopulmonary bypass (CPB). This is a prospective,
Gurian, Danilo Bortolotto   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy